Pilot Study Evaluating Safety of ExOlin® in Patients With Poorly Controlled Type 1 Diabetes
NCT05221359
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
8
Enrollment
INDUSTRY
Sponsor class
Conditions
Type 1 Diabetes
Type 1 Diabetes Mellitus With Hypoglycemia
Interventions
DEVICE:
ExOlin®
DRUG:
Insulin aspart
Sponsor
Defymed